Advances of LAPONITE®-based nanocarrier in drug delivery applications
Biomaterials Science · 2025 · 13 (18) · 4858-4884
DOI: 10.1039/d5bm00959f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2025. Verfasst von Jude Onojah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Howard University, Washington, DC 20059, USA. draghavan@howard.edu. Hauptthemen laut MEDLINE: Silicates, Drug Carriers, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: Howard University.
Abstract (Originalsprache)
This schematic illustrates the formation of a Laponite-based nanocarrier for drug delivery. The resulting hybrid system enables controlled drug release in response to stimuli such as pH, temperature, or light.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Howard University, Washington, DC 20059, USA. draghavan@howard.edu.
Förderung
- Howard University
Zitieren
APA
Onojah, J., Gebrehiwot, W., & Raghavan, D. (2025). Advances of LAPONITE®-based nanocarrier in drug delivery applications. Biomaterials Science, 13(18), 4858-4884. https://doi.org/10.1039/d5bm00959f
Vancouver
Onojah J, Gebrehiwot W, Raghavan D. Advances of LAPONITE®-based nanocarrier in drug delivery applications. Biomaterials Science. 2025;13(18):4858-4884. doi:10.1039/d5bm00959f
BibTeX
@article{Onojah2025,
author = {Onojah, Jude and Gebrehiwot, Weldejeworgis and Raghavan, Dharmaraj},
title = {Advances of LAPONITE®-based nanocarrier in drug delivery applications},
journal = {Biomaterials Science},
year = {2025},
volume = {13},
number = {18},
pages = {4858--4884},
doi = {10.1039/d5bm00959f}
}
EUVIMED